Learning to walk
暂无分享,去创建一个
[1] K. Zerres,et al. 93rd ENMC international workshop: non-5q-spinal muscular atrophies (SMA) – clinical picture (6–8 April 2001, Naarden, The Netherlands) , 2003, Neuromuscular Disorders.
[2] K. Davies,et al. 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17–19 April 1998, Soestduinen, The Netherlands , 1999, Neuromuscular Disorders.
[3] R. Finkel,et al. 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy11–13 February 2005Naarden, The Netherlands , 2005, Neuromuscular Disorders.
[4] T. Crawford. Concerns about the design of clinical trials for spinal muscular atrophy , 2004, Neuromuscular Disorders.
[5] A. D'Amico,et al. Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy , 2007, Neurology.
[6] J. Melki,et al. Spinal muscular atrophy: Recent advances and future prospects , 2002, Muscle & nerve.
[7] S. Iannaccone. Spinal Muscular Atrophy , 1998, Seminars in neurology.
[8] T. Wienker,et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. , 2002, American journal of human genetics.